Christopher Haqq Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Haqq.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Haqq. Christopher Haqq is a Chief Medical Officer in Atara Biotherapeutics, Inc. ($ATRA) and a EVP, R&D & Chief Scientific Of in Atara Biotherapeutics, Inc. ($ATRA).
Address: 3260 BAYSHORE BOULEVARD BRISBANE 94005 CA
Companies in which Christopher Haqq is an Insider
Atara Biotherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Christopher Haqq: EVP, R&D & Chief Scientific Of, Chief Medical Officer
Holdings: 272,718 shares
Current Value: $4,104,406
Latest Transaction: Feb 11 2019
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Christopher Haqq
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2019 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 38.55 | 13,975 | 538,736 | 272,718 | 286.7 K to 272.7 K (-4.87 %) |
| Nov 15 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 33.81 | 775 | 26,203 | 285,580 | 286.4 K to 285.6 K (-0.27 %) |
| Sep 27 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 43.08 | 13,500 | 581,580 | 286,355 | 299.9 K to 286.4 K (-4.50 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 41.23 | 3,500 | 144,305 | 299,855 | 303.4 K to 299.9 K (-1.15 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.26 | 10,000 | 402,600 | 303,355 | 313.4 K to 303.4 K (-3.19 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 40.53 | 3,931 | 159,323 | 313,355 | 317.3 K to 313.4 K (-1.24 %) |
| Sep 25 2018 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 39.74 | 14,069 | 559,102 | 317,286 | 331.4 K to 317.3 K (-4.25 %) |